Antidepressants abuse in subjects with opioid use disorders: A 10‐year study in the French OPPIDUM program-Reference-Cited by-同舟云学术

Antidepressants abuse in subjects with opioid use disorders: A 10‐year study in the French OPPIDUM program

Published:2021-12-08 Issue: Volume: Page:
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundamemntal Clinical Pharma

Author:

Dumonceau Robinson Gravier¹,Soeiro Thomas¹²^ORCID,Lacroix Clémence¹²,Giocanti Adeline¹,Frauger Élisabeth¹,Mezaache Salim¹,Micallef Joëlle¹²^ORCID

Affiliation:

1. Assistance publique – Hôpitaux de Marseille, Service de pharmacologie clinique Centre d'Évaluation et d'information sur la pharmacodépendance – Addictovigilance PACA Corse Marseille France

2. Aix‐Marseille Université Inserm, UMR 1106 Marseille France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12738

Reference33 articles.

1. Prescription Drug Abuse: Insight Into the Epidemic

2. Abuse and misuse of antidepressants

3. Characteristics of tianeptine effects reported to a poison control center: a growing threat to public health

4. The FDA and the Next Wave of Drug Abuse — Proactive Pharmacovigilance

5. Signal Identification in Addictovigilance: the Functioning of the French System

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of Pregabalin Users from Substance Abuse Treatment Facilities: Results from the French OPPIDUM Program from 2008 to 2022;CNS Drugs;2024-07-11

2. Postmortem toxicology findings from the Camden Opioid Research Initiative;PLOS ONE;2023-11-01

3. Systematic assessment of non‐medical use of prescription drugs using doctor‐shopping indicators: A nation‐wide, repeated cross‐sectional study;Addiction;2023-06-12

4. Clomipramine Misuse in a Patient with Schizophrenia;ADDICTA: The Turkish Journal on Addictions;2023-04-11

5. Increase of cannabis and cocaine use by pregnant women in France from 2005 to 2018: Insights of the annual cross sectional OPPIDUM survey;Therapies;2023-03